Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

New early marker in Parkinson’s disease

Published on: 29/01/2014 Reading time: 1 min
Le complexe coeruleus/subcoeruleus est visible dans cette nouvelle sequence IRM. Cela nous a permis d’étudier la relation entre cette petite structure (en blanc dans l’image) et le tonus musculaire pendant le sommeil paradoxal.

A paper published in the prestigious journal Brain by a team of the Institut du Cerveau - ICM institute link rapid eye movement sleep disorders and Parkinson’s disease. These results open the possibilities to early diagnose development of the Parkinson’s disease.

Parkinson disease is a progressive degenerative neurological disorder affecting 150 000 persons in France. It is characterized by the death of a neuronal population producing dopamine, a neurotransmitter, chemical messenger allowing transmission of informations between neurons. The diminution of the concentration of dopamine is the source of the development of the disease. Indeed, symptoms arise when 60-80% of these specific neurons disappear.

These last few years, researchers studied non-dopaminergic symptoms and more notably rapid eye movement sleep behavior disorder affecting 30 to 60% of patients. Rapid eye movement sleep is traditionally characterized by dreams and is associated with a strong neuronal activity, ocular movements and diminution of muscle tone. Some patients with Parkinson disease have rapid eye movement sleep behavior disorders with increased muscular tone which could lead to nocturnal violence. Rapid eye movement sleep behavior disorders could arise in any healthy subject whithout neurological disease. However, these persons present a higher risk to develop Parkinson disease or demencia. Daniel GarcÍa-Lorenzo in the team of Marie Vidailhet et Stéphane Lehéricy just highlighted the role of a part of the brain named the coeruleus/subcoeruleus complex in the blocking of muscle tone during eye rapid movement sleep.

The team studied the integrity of this complex in patients with Parkinson’s disease using imaging approaches. They showed that patients with Parkinson’s disease have a reduced neuronal activity in the coeruleus/subcoeruleus complex associated with rapid eye movement sleep behavior disorder. Imaging datas combined with careful clinical evaluation as well as nocturnal video monitoring may be used as an early marker of non-dopaminergic Parkison’s disease pathology to predict the occurrence of Parkinson’s disease.

Le complexe coeruleus/subcoeruleus est visible dans cette nouvelle sequence IRM. Cela nous a permis d’étudier la relation entre cette petite structure (en blanc dans l’image) et le tonus musculaire pendant le sommeil paradoxal.
The coeruleus/subcoeruleus complex is visible in this new MRI sequence. This allowed us to study the relation between these small structures (in white on the image) and the muscle tone during rapid eye movement sleep.

Sources

Garcia-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, Leu-Semenescu S, Gallea C, Quattrocchi G, Lobo PP, Poupon C, Benali H, Arnulf I, et al.: The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s disease. Brain 2013, 136:2120-2129.

Our news on the subject

Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them...
09.10.2024 Research, science & health
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain...
09.05.2024 Research, science & health
Un neurone
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol...
07.16.2024 Research, science & health
Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and...
06.28.2024 Research, science & health
Une tête de statue de l'île de Pâques sur laquelle sont posées des éléctrodes
A multimodal approach to better predict recovery in patients with disorders of consciousness
When a patient is admitted to intensive care due to a disorder of consciousness—such as a coma—establishing their neurological prognosis is a crucial yet challenging task. To reduce the uncertainty that precedes the medical decision, a group of...
05.30.2024 Research, science & health
Population de bactéries commensales (en rouge) dans un intestin grêle de souris. Crédit : University of Chicago
The composition of the gut microbiota could influence decision-making
The way we make decisions in a social context can be explained by psychological, social, and political factors. But what if other forces were at work? Hilke Plassmann and her colleagues from the Paris Brain Institute and the University of Bonn show...
05.16.2024 Research, science & health
See all our news